Eliquis had a market value of $14 billion during the 12 months ended May 2021, according to industry data. The Food and Drug Administration has cleared Breckenridge’s apixaban tablets. The medication ...

Apotex, a Canadian manufacturer of generics, recently introduced APO-Apixaban tablets, Canada's first generic alternative to Bristol-Myers Squibb’s Eliquis. Apotex's apixaban is an oral anticoagulant ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Bristol Myers Squibb and Pfizer will begin offering ...

Global sales of Bristol Myers Squibb’s and Pfizer’s drug Eliquis (apixaban) are projected to decline by 15.2% in 2026 due to ...

BMY's legacy drugs see sharp generic erosion in 2026, but Eliquis growth and guidance shape expectations as competition heats ...

The popular diabetes treatment Jardiance and the blood thinner Eliquis are among the first drugs that will be targeted for price negotiations in effort to cut Medicare costs. President Joe Biden's ...

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

Drugmaker Bristol Myers Squibb posted slightly better-than-expected first-quarter earnings on Friday on growth of sales of its blood thinner Eliquis and cancer drug Opdivo, but said it no longer ...

DEAR DR. ROACH: My husband is taking Eliquis for atrial fibrillation (AFib). The cost is going up, and there is no generic brand for Eliquis. Looking at drug websites, I have found other drugs that ...